EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Repurposing Artemisinin-Based Drugs from Antimalarial to Pan-Therapeutic: Pharmacological Promise and Therapeutic Challenges

Di Wu, Hong Zeng, Jiachen Tan, Qinzheng Xu, Faheem Ahmed Khan, Nuruliarizki Shinta Pandupuspitasari, Shengqiang Yang, Chunjie Huang iD

Drug Design, Development and Therapy · 2025-10 · Volume 19 · 9199-9226

DOI: 10.2147/dddt.s545163 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2025-10. Verfasst von Di Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nantong University, Nantong, 226001, People's Republic of China. Hauptthemen laut MEDLINE: Artemisinins, Antimalarials, Drug Repositioning, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 253 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArtemisininsAntimalarialsDrug RepositioningNeoplasmsAntineoplastic AgentsHumansMedicine, Chinese TraditionalAnimalsAlzheimer Disease

Stichwörter der Autor:innen

artemisinindrug deliverymalignancyneurodegenerative diseasereproductive disorder

Substanzen

ArtemisininsAntimalarialsAntineoplastic Agentsartemisinin

Autor:innen und Institutionen

  • School of Medicine, Nantong University, Nantong, 226001, People's Republic of China.
  • School of Basic Medicine, Youjiang Medical University for Nationalities, Baise, 533000, People's Republic of China.
  • Department of Obstetrics and Gynecology, Affiliated Hospital of Nantong University, Nantong, 226001, People's Republic of China.
  • Research Center for Animal Husbandry, National Research and Innovation Agency, Jakarta Pusat, 10340, Indonesia.
  • Faculty of Animal and Agricultural Sciences, Universitas Diponegoro, Semarang, 50275, Indonesia.

ORCID-Profile: Chunjie Huang

Zitieren

APA

Wu, D., Zeng, H., Tan, J., Xu, Q., Khan, F. A., Pandupuspitasari, N. S., Yang, S., & Huang, C. (2025). Repurposing Artemisinin-Based Drugs from Antimalarial to Pan-Therapeutic: Pharmacological Promise and Therapeutic Challenges. Drug Design, Development and Therapy, Volume 19, 9199-9226. https://doi.org/10.2147/dddt.s545163

Vancouver

Wu D, Zeng H, Tan J, Xu Q, Khan FA, Pandupuspitasari NS, et al. Repurposing Artemisinin-Based Drugs from Antimalarial to Pan-Therapeutic: Pharmacological Promise and Therapeutic Challenges. Drug Design, Development and Therapy. 2025;Volume 19:9199-9226. doi:10.2147/dddt.s545163

BibTeX
@article{Wu2025,
  author = {Wu, Di and Zeng, Hong and Tan, Jiachen and Xu, Qinzheng and Khan, Faheem Ahmed and Pandupuspitasari, Nuruliarizki Shinta and Yang, Shengqiang and Huang, Chunjie},
  title = {Repurposing Artemisinin-Based Drugs from Antimalarial to Pan-Therapeutic: Pharmacological Promise and Therapeutic Challenges},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  volume = {Volume 19},
  pages = {9199--9226},
  doi = {10.2147/dddt.s545163}
}
Kostenlos starten →